Laura Shaughnessy

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study

Xavier Mariette, Frauke Förger, Bincy Abraham et al. · Annals of the Rheumatic Diseases · 2017 · 393 citations · Full text

Medicine, Obstetrics, Pharmacology +14

Pregnancy Outcomes After Exposure to Certolizumab Pegol

Megan E. B. Clowse, Angela E. Scheuerle, Christina Chambers et al. · Arthritis & Rheumatology · 2018 · 182 citations · Full text

Medicine, Obstetrics, Pharmacology +14

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study

Megan E. B. Clowse, Frauke Förger, Caroline Hwang et al. · Annals of the Rheumatic Diseases · 2017 · 174 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Ghrelin receptor agonist (TZP‐101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis

Esben Thyssen Vestergaard, Per M. Hellström, Lars Christian Gormsen et al. · Alimentary Pharmacology & Therapeutics · 2009 · 122 citations

Medicine, Endocrinology, Pharmacotherapy +16

Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study

Georg Dimcevski, John M. Wo, Per M. Hellström et al. · Neurogastroenterology & Motility · 2010 · 113 citations

Medicine, Pharmacology, Pharmacotherapy +12